- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 307/14 - Radicals substituted by nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 307/14
Total number of patents in this class: 174
10-year publication summary
|
7
|
12
|
16
|
14
|
13
|
10
|
11
|
6
|
18
|
3
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Anavex Life Sciences Corp. | 61 |
20 |
| Mitsubishi Gas Chemical Company, Inc. | 3188 |
8 |
| Novartis AG | 11238 |
5 |
| Archer Daniels Midland Company | 1164 |
5 |
| Janssen Pharmaceutica N.V. | 3839 |
4 |
| Sumitomo Chemical Company, Limited | 8808 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
4 |
| Toyama Chemical Co., Ltd. | 114 |
4 |
| BASF SE | 19740 |
3 |
| Wisconsin Alumni Research Foundation | 3774 |
3 |
| Mitsui Chemicals, Inc. | 3134 |
3 |
| Agios Pharmaceuticals, Inc | 200 |
3 |
| HAPLOGEN GmbH | 9 |
3 |
| Sanofi | 3836 |
3 |
| Spirify Pharma Inc | 8 |
3 |
| The Procter & Gamble Company | 22178 |
2 |
| Genentech, Inc. | 3742 |
2 |
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
2 |
| Merial, Inc. | 236 |
2 |
| Newron Pharmaceuticals S.p.A. | 72 |
2 |
| Other owners | 89 |